Catabasis Pharmaceuticals today announced a restructuring of the organization to focus resources on the Company’s late-stage lead program, edasalonexent for the treatment of Duchenne muscular... read more
Catabasis Pharmaceuticals today announced a restructuring of the organization to focus resources on the Company’s late-stage lead program, edasalonexent for the treatment of Duchenne muscular... read more
Elios Therapeutics, a biopharmaceutical company developing particle-delivered, dendritic cell vaccines in the oncology arena, today presented initial open-label results from the ongoing Phase 2b ... read more
The drive to bring more transparency to healthcare costs can be seen at both the federal and state levels (see some... read more
Torque, an immuno-oncology company developing Deep Primed cellular therapies with pharmacologic control to direct immune power deep within the tumor microenvironment, announced today preclinical... read more
Arrevus Inc. (www.arrevus.com), an early stage biotechnology company focused on developing chaperone protein inhibitors for infectious diseases, today... read more